Rituximab Treatment of Graves' Dysthyroid Ophthalmopathy
Status:
Completed
Trial end date:
2009-03-01
Target enrollment:
Participant gender:
Summary
This study is designed to treat patients with Graves' disease with Rituximab in an attempt to
prevent or reverse the physically deforming and debilitating consequences of this disease.
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
Silkiss, Rona Z., M.D., FACS
Collaborators:
Coleman, Morton M.D. Lauer, Simeon, M.D. Reier, Alice M.D.